Rapid AST in bloodcultures

RAST: Screening for resistance mechanisms of epidemiological and/or infection control importance

Screening for R-mechanisms with RAST

Some resistance mechanisms require other than clinical breakpoints for sensitive detection. 
EUCAST recommends screening for a number of resistance mechanisms for epidemiological and infection control purposes (see separate document). 

 

EUCAST has validated using separate screening cut-offs for the detection of E. coli and K. pneumoniae with ESBL or carbapenemases. 

Screening for resistance mechanisms using RAST (12 April 2022)

 

Archived:

Screening for resistance mechanisms using RAST (valid until 12 April, 2022)

 

 

 

 

 

Published 2 May, 2019